DoseMe Buys Clinical Decision Support Platform Firstline
DoseMe, a portfolio company of private equity firm Fairlong Capital, announced on November 3 its acquisition of Vancouver, Canada-based Firstline. Firstline is a mobile-first clinical decision support platform. It enables clinicians to rapidly access local, evidence-based infectious disease treatment guidance, susceptibility patterns and antimicrobial stewardship resources. Headquartered in Jupiter, Florida, DoseMe is a global leader in model-informed precision dosing software. DoseMe optimizes non-time-critical dosing for antimicrobials, oncology agents, immunosuppressants and more, reducing drug-related risks. The combination of DoseMe and Firstline creates a single, connected experience... Read More »
Salt Dental Partners Announces 10th Acquisition of 2025
On October 29, SALT Dental Partners announced that it expanded its New Jersey presence with the acquisition of Brick Pediatric Dentistry and Orthodontic. The financial terms of the transaction were not disclosed. Based in Brick, New Jersey, Brick Pediatric Dentistry and Orthodontic has two physicians on staff: Dr. Dawn Chillemi and Dr. Seymour Semah. Headquartered in Phoenix, Arizona, SALT Dental Partners is a dental partnership organization focused on specialty pediatric dentistry and orthodontics with more than 90 locations across 13 states throughout the country. SALT is a portfolio company of Latticework Capital Partners, a Dallas, Texas-based private equity firm. ... Read More »
RC Capital Partners With The Blanchard Institute of North Carolina
RC Capital announced on October 30 a new platform investment in The Blanchard Institute for an undisclosed price. The Blanchard Institute is a North Carolina–based provider of intensive outpatient and partial hospitalization behavioral health services. The company offers a comprehensive continuum of mental health and substance use services. Founded in 1994, RC Capital is a healthcare-focused growth equity firm based in Cincinnati, Ohio. The firm seeks to invest in commercial-stage medical technology companies operating in the healthcare services, medical devices and healthcare information technology sectors. “The growth investment in The Blanchard Institute underscores RC Capital’s... Read More »LevinPro HC Stat of the Week, October 31, 2025
What Physician Specialties Are Private Equity Firms After? *This data includes any physician specialty with less than 2% of overall deal activity Editor’s Commentary: Throughout 2025, dental practices have been the clear favorite for roll-up acquisitions by private equity firms and their sponsored platforms. This year’s trend mirrors activity we captured in 2024 and 2023 on our LevinPro HC platform, with dental drawing most of the attention in private equity investments and funding for years now. The volume of activity makes sense when you examine the tailwinds: a fragmented market, stable cash flows and the promise of a DSO’s ability to generate higher margins at scale.... Read More »
PE-Backed BioMatrix Infusion Pharmacy Closes Acquisition of LUX Infusion
BioMatrix Infusion Pharmacy, backed by private equity firm Frazier Healthcare Partners, announced the successful acquisition of LUX Infusion, effective October 17, 2025. With this acquisition, BioMatrix extends its reach into the Pacific Northwest. Financial terms of the deal were not disclosed. LUX Infusion is Alaska’s leading independent ambulatory infusion provider, offering safe, convenient and cost-effective care for patients with acute and chronic conditions. The company has three locations across the state. Headquartered in Plantation, Florida, BioMatrix Infusion Pharmacy is a nationwide, independent specialty infusion pharmacy. Frazier Healthcare Partners acquired the company... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
